Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factor XI inhibitors: cardiovascular perspectives.
De Caterina R, Prisco D, Eikelboom JW. De Caterina R, et al. Among authors: eikelboom jw. Eur Heart J. 2023 Jan 21;44(4):280-292. doi: 10.1093/eurheartj/ehac464. Eur Heart J. 2023. PMID: 36263776 Review.
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
ACTIVE Investigators; Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. ACTIVE Investigators, et al. N Engl J Med. 2009 May 14;360(20):2066-78. doi: 10.1056/NEJMoa0901301. Epub 2009 Mar 31. N Engl J Med. 2009. PMID: 19336502 Free article. Clinical Trial.
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
Diener HC, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J, Ezekowitz MD, Granger CB, Halperin JL, Hohnloser SH, Hylek EM, Kirchhof P, Lane DA, Verheugt FWA, Veltkamp R, Lip GYH. Diener HC, et al. Eur Heart J. 2017 Mar 21;38(12):852-859. doi: 10.1093/eurheartj/ehv643. Eur Heart J. 2017. PMID: 26848149 Free PMC article. Review.
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
Diener HC, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J, Ezekowitz MD, Granger CB, Halperin JL, Hohnloser SH, Hylek EM, Kirchhof P, Lane DA, Verheugt FWA, Veltkamp R, Lip GYH. Diener HC, et al. Eur Heart J. 2017 Mar 21;38(12):860-868. doi: 10.1093/eurheartj/ehw069. Eur Heart J. 2017. PMID: 26848150 Free PMC article. Review.
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.
Verheugt FWA, Gao H, Al Mahmeed W, Ambrosio G, Angchaisuksiri P, Atar D, Bassand JP, Camm AJ, Cools F, Eikelboom J, Kayani G, Lim TW, Misselwitz F, Pieper KS, van Eickels M, Kakkar AK; GARFIELD-AF Investigators. Verheugt FWA, et al. Eur Heart J. 2018 Feb 7;39(6):464-473. doi: 10.1093/eurheartj/ehx730. Eur Heart J. 2018. PMID: 29281086
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
De Caterina R, Agewall S, Andreotti F, Angiolillo DJ, Bhatt DL, Byrne RA, Collet JP, Eikelboom J, Fanaroff AC, Gibson CM, Goette A, Hindricks G, Lip GYH, Potpara T, Thiele H, Lopes RD, Galli M. De Caterina R, et al. Eur Heart J. 2022 Oct 7;43(37):3512-3527. doi: 10.1093/eurheartj/ehac294. Eur Heart J. 2022. PMID: 35925556 No abstract available.
590 results